Communiqués

11/08 Codexis: Q2 Earnings Snapshot AQ
11/08 Codexis Reports Second Quarter 2026 Financial Results AQ
03/08 Codexis Appoints David Butler, PhD, to Strategic Advisory Board AQ
29/07 Codexis to Report Second Quarter 2026 Financial Results on August 11 AQ
28/07 Codexis to Report Second Quarter 2026 Financial Results on August 11 AQ
27/07 Codexis Announces Proposed Public Offering of Common Stock - July 23, 2026 AQ
27/07 Codexis Announces Pricing of Public Offering of Common Stock - July 23, 2026 AQ
27/07 Codexis Announces Pricing of Public Offering of Common Stock AQ
24/07 Codexis Announces Pricing of Public Offering of Common Stock AQ
23/07 Codexis Announces Proposed Public Offering of Common Stock AQ
20/05 Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA AQ
08/05 Codexis : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) PU
07/05 Codexis: Q1 Earnings Snapshot AQ
07/05 Codexis Reports First Quarter 2026 Financial Results AQ
29/04 Codexis to share RNA manufacturing advances at TIDES USA AQ
23/04 Codexis to Report First Quarter 2026 Financial Results on May 7 AQ
11/03 Codexis: Q4 Earnings Snapshot AQ
11/03 Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results AQ
25/02 Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 AQ
17/02 Codexis to Participate in TD Cowen 46th Annual Health Care Conference AQ
10/02 Codexis Achieves ISO 9001:2015 Certification AQ
10/11 Codexis Announces Signing of Lease for GMP Manufacturing Facility AQ
07/11 Codexis: Q3 Earnings Snapshot AQ
07/11 Codexis : CDXS Q3 2025 Earnings Deck PU
07/11 Codexis : Presentation Q3 2025 PU
Aucun résultat pour cette recherche